In light of that oncogenic KRT7 promotes carcinogenesis [20–24, 28–37] and the binding of antisense mRNAs to complementary sense mRNAs usually causes degradation of the sense mRNAs in cells [22], we first investigated whether KRT7-AS reduces KRT7 levels in cancers. The gene discussed is KRT7; the disease is cancer.